FSA Set Official Deadline for CBD Products to submit Valid Novel Food Authorisation Applications

Fera

FSA Set Official Deadline for CBD Products to submit Valid Novel Food Authorisation Applications

Cannabidiol (CBD) is a non-psychoactive cannabinoid found in cannabis and the term “CBD” is often used to describe CBD-containing consumer products. CBD extracts can be found in a range of products such as oils, confectionery, bakery products and drinks.


CBD product use has grown significantly in the UK within the last year, with recent research commissioned by the Centre for Medicinal Cannabis revealing that the UK CBD market is worth £300 million, and is forecast to grow to >£1 billion by 2025.|

Announcing today on BBC Breakfast, Emily Miles, Chief Executive of the Food Standards Agency (FSA), is making it clear to industry that any CBD product producers who wish to sell their products in the UK ‘has a deadline of 31 March 2021 to submit valid novel food authorisation applications. After 31 March next year, only products which have submitted a valid application will be allowed to remain on the market. The authorisation process ensures novel foods meet legal standards, including on safety and content.’


Recent testing at Fera Science Limited (Fera) found levels of environmental contaminants, THC and CBN in CBD products currently on sale in the UK. Fera also found that the level of CBD in some products was very different to that shown on the label. Therefore, it is extremely important that all manufacturers/retailers take immediate action to apply for novel food authorisation in relation to any CBD extract products sold - or plan to sell in the future - in the UK. This also includes looking to seek assurances from suppliers/manufacturers that they have done so, we can support CBD manufacturers and producers with this marketing authorisation to determine its safety and import/export compliance.


For more than 20 years, government and industry have turned to Fera’s food safety analytical chemists when they need clarity and solutions to the industry’s most complex issues. Clients value our deep industry knowledge, rigorous analytical techniques, and decades of hands-on experience spanning thousands of successful engagements. Clients rely on Fera’s objective point of view and innovative insights when they want a new way to look at their most complex problems. See how we can help you today.


For further information about routine testing, please visit:


CBD Testing



Share:

Copyright © 2020 Fera Science Limited (“Fera”). All rights reserved.
Registered Office: 30 Berners Street, London, W1T 3LR. Registered in England & Wales, No 9413107. Fera is a joint venture company of Capita Plc, 30 Berners Street, London, W1T 3LR. Registered in England and Wales No 02081330. VAT Registration ID: GB 618184140
For further information about how Fera uses any personal data collected from you, please see our Privacy Notice at www.fera.co.uk/privacy-policy.